88
Growth Score in past quarter
pts
Heat Score 88 in past quarter
31 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
858722
20Sense provides pharmaceutical market access consulting, RWE/OBA working groups, PSP forums, and publishes The 20Sense Report.
- Allison Wills: Founder and Partner
- Allison Wills: Publisher, The 20Sense Report
About the Company
20Sense is a pharmaceutical research and consulting firm focused on Canadian drug access, pricing, and real-world evidence. The company convenes the RWE+OBA Think Tank and Patient Support Program Leaders Forum to develop outcomes-based agreement models, PSP standards, and data frameworks. 20Sense advises payers, manufacturers, and health
organizations on managed access pathways and innovative payment models. It also publishes The 20Sense Report, a quarterly magazine offering analysis on pharmaceutical access, value, and specialty care topics.